Semi-annual Report for 2026
Filed with SSE · · 209 pages · Chinese
Jiangsu Lianhuan Pharmaceutical Co., Ltd. on 6ix
Earlier from Jiangsu Lianhuan Pharmaceutical
- Announcement on the Addition of a Related Party Not Under Common Control and Increase of the Estimated Amount of Routine Related Party Transactions for 2026
- Announcement on Resolutions of the 26th Extraordinary Meeting of the 9th Board of Directors
- Announcement on Obtaining Drug Registration Certificate
- Announcement on the Proposed Selection of the Company and Controlled Subsidiary in the 12th Batch of National Centralized Drug Procurement
- Investor Relations Activity Record Form
Later from Jiangsu Lianhuan Pharmaceutical
- Announcement on Convening the 2026 Semi-annual Performance Briefing
- Announcement on Resolutions of the 2nd Extraordinary General Meeting in 2026
- Announcement on Outline of the 2026 Semi-annual Performance Briefing
- (600513)"Jiangsu Lianhuan Pharmaceutical Co., Ltd."Announcement on Receipt of Approval Notice for Drug Supplementary Application
- (600513)"Jiangsu Lianhuan Pharmaceutical Co., Ltd."Indicative Announcement on Acceptance of Application for Drug Marketing Authorization
Follow Jiangsu Lianhuan Pharmaceutical into a list and get an email when it puts out news.
Follow Jiangsu Lianhuan Pharmaceutical